Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Sarah Dobrozsi"'
Publikováno v:
American Society of Clinical Oncology Educational Book. :573-581
Hearing that a child has been diagnosed with cancer is invariably difficult for both patients and their caregivers. Effective communication among patients, caregivers, and medical teams is necessary not only to deliver information and facilitate canc
Autor:
Harald Kliems, Christopher B. Forrest, Wendy E. Gerhardt, Sarah Dobrozsi, Carole A. Tucker, Lindsay A. Thompson, Elizabeth D. Cox, Thuy Dan N. Tran, Bryce B. Reeve, Jacob M. Svenson, Nan E. Rothrock, Jin Shei Lai
Publikováno v:
J Pediatr
Objective To identify challenges to the use of Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric measures in the ambulatory pediatric setting and possible solutions to these challenges. Study design Eighteen semistructured t
Publikováno v:
Pediatr Blood Cancer
Prognostic communication is essential to family-centered care in pediatric oncology. Yet, prognostic communication from the medical team to the family is often absent or incomplete. In our experience, many clinical groups view prognostic disclosure a
Publikováno v:
Transfusion. 60:1108-1109
Autor:
Andreana Bütter, Katheryn Hope Wilkinson, Katrina M Morgan, Hau D. Le, Kevin C. Janek, Abigail K. Zamora, Sarah Dobrozsi, Oswaldo Gomez Quevedo, Nelson Piché, Kaitlyn E. Wong, Andrew J. Murphy, Rosemarie Mastropolo, Jacob D. Davidson, Eugene S. Kim, Akila B. Ramaraj, Whitney Weinschenk, Dave R. Lal, Joseph T. Murphy, Jennifer H. Aldrink, Rebecca Stark, Elisabeth T. Tracy, Scott S. Short, Jenna Rossoff, Michael V. Ortiz, Benjamin T. Many, Jo Cooke-Barker, Lindsay J. Talbot, Nawar Dakhallah, Eveline Lapidus-Krol, Reto M. Baertschiger, Sarah Jane Commander, Catherine J. Goodhue, Todd E. Heaton, Marcus M. Malek, Roshni Dasgupta, Rebecka L. Meyers, Hannah N. Rinehardt, Timothy B Lautz, Annie Le-Nguyen
Publikováno v:
Paediatrics Publications
BACKGROUND: Optimal management of neutropenic appendicitis (NA) in children undergoing cancer therapy remains undefined. Management strategies include upfront appendectomy or initial nonoperative management. We aimed to characterize the effect of man
Autor:
Maureen Haugen, Jeneane Sullivan, Marilyn J. Hockenberry, Kathleen S. Ruccione, Kristin Bingen, Ruth Anne Herring, Mary C. Hooke, JoAnn Ahern, Susan L. Cohn, Kathryn Murphy, Lamia P. Barakat, Melissa Martin, Marianne E. Weiss, Janice S. Withycombe, Lise Yasui, Patricia G. Bondurant, Cheryl Rodgers, Sarah Dobrozsi, Smita Bhatia, Wendy Landier, Amy Rose Newman
Publikováno v:
Journal of Pediatric Oncology Nursing. 33:422-431
There is a paucity of data to support evidence-based practices in the provision of patient/family education in the context of a new childhood cancer diagnosis. Since the majority of children with cancer are treated on pediatric oncology clinical tria
Autor:
Sarah Dobrozsi, Bruce M. Camitta, Robert Peter Gale, Syed Ali Abutalib, Hillard M. Lazarus, Armand Keating, Julie-An Talano, Andrea Bacigalupo, Reinhold Munker, Kerry Atkinson
Publikováno v:
Hematopoietic Cell Transplants: Concepts, Controversies, and Future Directions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::746f721e588974df9640069bfee2c395
https://doi.org/10.1017/9781316335727.032
https://doi.org/10.1017/9781316335727.032
Autor:
Sarah, Dobrozsi, Julie, Panepinto
Publikováno v:
Pediatric bloodcancer. 64(10)
Patient-reported outcome measures (PROs) generate reproducible, objective measures of patient functioning and symptoms. Clinical PRO use has proven benefits. Parent and child preferences for the graphical display of PRO data are not known. We conduct
Publikováno v:
Blood. 134:4743-4743
BACKGROUND Overall survival for adolescent and young adult (AYA) cancer population, ages 15 to 39 years, demonstrated minimal improvement during the last several decades. Potential factors influencing inferior outcomes within this group include the c
Publikováno v:
Pediatric bloodcancer. 64(4)
Changes in patient function and factors affecting pediatric patients with cancer during treatment are largely unknown. The purpose of this study was to measure patient-reported outcomes (PROs) in children during the initial 6 months of therapy to cha